2025 TNACC Annual State Meeting- Evaluation

Please take a moment to provide your feedback for the following activity.

2025 TNACC Annual State Meeting

Friday, November 14 and Saturday, November 15, 2025 • Nashville, TN

How well were the overall learning objectives met?

	Excellent	Good	Average	Fair	Poor	N/A
Apply the most recent research in treatment of cardiology issues in women.	Apply the most recent research in treatment of cardiology issues in women. - Excellent	Apply the most recent research in treatment of cardiology issues in women. - Good	Apply the most recent research in treatment of cardiology issues in women. - Average	Apply the most recent research in treatment of cardiology issues in women. - Fair	Apply the most recent research in treatment of cardiology issues in women. - Poor	Apply the most recent research in treatment of cardiology issues in women. - N/A
Discuss the new acute coronary syndrom guidelines.	Discuss the new acute coronary syndrom guidelines. - Excellent	Discuss the new acute coronary syndrom guidelines. - Good	Discuss the new acute coronary syndrom guidelines. - Average	Discuss the new acute coronary syndrom guidelines. - Fair	Discuss the new acute coronary syndrom guidelines. - Poor	Discuss the new acute coronary syndrom guidelines. - N/A
Identify drugs that affect mortality in pulmonary arterial hypertension.	Identify drugs that affect mortality in pulmonary arterial hypertension. - Excellent	Identify drugs that affect mortality in pulmonary arterial hypertension. - Good	Identify drugs that affect mortality in pulmonary arterial hypertension. - Average	Identify drugs that affect mortality in pulmonary arterial hypertension. - Fair	Identify drugs that affect mortality in pulmonary arterial hypertension. - Poor	Identify drugs that affect mortality in pulmonary arterial hypertension. - N/A
Review procedures for computed tomography angiography.	Review procedures for computed tomography angiography. - Excellent	Review procedures for computed tomography angiography. - Good	Review procedures for computed tomography angiography. - Average	Review procedures for computed tomography angiography. - Fair	Review procedures for computed tomography angiography. - Poor	Review procedures for computed tomography angiography. - N/A
Evaluate GLP-1 therapy in cardiovascular disease.	Evaluate GLP-1 therapy in cardiovascular disease. - Excellent	Evaluate GLP-1 therapy in cardiovascular disease. - Good	Evaluate GLP-1 therapy in cardiovascular disease. - Average	Evaluate GLP-1 therapy in cardiovascular disease. - Fair	Evaluate GLP-1 therapy in cardiovascular disease. - Poor	Evaluate GLP-1 therapy in cardiovascular disease. - N/A

Give one or two examples of patient outcomes that will be directly impacted as a result of attending this symposium.

What specific changes will you make in your practice because of attending this symposium?

Was the material presented in a manner that was free from commercial bias? *

Yes

No - Please describe -

Was the material presented in a manner that was free from commercial bias? No - Please describe -

Please provide any additional comments or suggestions.

Leave this field blank

You are here

2025 TNACC Annual State Meeting- Evaluation